辅舒酮雾化吸入用混悬剂 2ml:0.5mg China - Chinese - CFDA (药监局 - 中国食品和药物管理局)

辅舒酮雾化吸入用混悬剂 2ml:0.5mg

glaxosmithkline australia pty ltd. - 丙酸氟替卡松 - 雾化吸入用混悬剂 - 2ml:0.5mg

万托林吸入溶液剂 5mg/2.5ml China - Chinese - CFDA (药监局 - 中国食品和药物管理局)

万托林吸入溶液剂 5mg/2.5ml

glaxosmithkline australia pty ltd. - 硫酸沙丁胺醇 - 吸入溶液剂 - 5mg/2.5ml

癌康定膠囊0.25毫克 Taiwan - Chinese - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

癌康定膠囊0.25毫克

台灣諾華股份有限公司 台北市中山區民生東路三段2號8樓 (01516589) - topotecan hydrochloride - 膠囊劑 - topotecan hydrochloride (1013000310) (0.25mg)mg - topotecan - 復發性小細胞肺癌。

癌康定膠囊1毫克 Taiwan - Chinese - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

癌康定膠囊1毫克

台灣諾華股份有限公司 台北市中山區民生東路三段2號8樓 (01516589) - topotecan hydrochloride - 膠囊劑 - topotecan hydrochloride (1013000310) (1mg)mg - topotecan - 復發性小細胞肺癌。

嬰護寧六合一疫苗 Taiwan - Chinese - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

嬰護寧六合一疫苗

荷商葛蘭素史克藥廠股份有限公司台灣分公司 台北市中正區忠孝西路一段66號23-24樓 (86927438) - pertussis toxoid;;diphtheria toxoid;;tetanus toxoid;;pertactin;;filamentous haemagglutinin;;r-dna hepatitis b surface antigen adsorbed (hbsag);;inactivated polio virus -type 1;;inactivated polio virus - type 2;;inactivated polio virus -type 3;;conjugated of haemophilus influenzae type b capsular polysaccharide (prp) and tetanus toxoid (t), adsorbed - 凍晶注射劑 - pertussis toxoid (8004001620) ug; diphtheria toxoid (8008000100) i.u.; tetanus toxoid (8008000200) i.u.; inactivated polio virus -type 1 (8012003100) du; inactivated polio virus - type 2 (8012003200) du; inactivated polio virus -type 3 (8012003300) du; conjugated of haemophilus influenzae type b capsular polysaccharide (prp) and tetanus toxoid (t), adsorbed (8012004000) (10up of prp and 20-; r-dna hepatitis b surface antigen adsorbed (hbsag) (8081223400) ug; filamentous haemagglutinin (9200050300) ug; pertactin (9900066600) ug - diphtheria-haemophilus influenzae b-pertussis-poliomyelitis-tetanus-hepatitis b - infanrix hexa 適用於6週大以上之嬰兒及幼童的基礎免疫接種及追加接種,以對抗白喉、破傷風、百日咳、b型肝炎、小兒麻痺及b型嗜血桿菌。

必思諾B型腦膜炎雙球菌疫苗 Taiwan - Chinese - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

必思諾b型腦膜炎雙球菌疫苗

荷商葛蘭素史克藥廠股份有限公司台灣分公司 台北市中正區忠孝西路一段66號23-24樓 (86927438) - recombinant neisseria meningitidis group b nhba fusion protein (rp287-953);;recombinant neisseria meningitidis group b nada protein (rp961c);;recombinant neisseria meningitidis group b fhbp fusion protein (rp936-741);;outer membrane vesicles (omv) from neisseria meningitidis group b strain nz98/254 measured as amount of total protein containing the pora p1.4 - 懸浮注射液 - recombinant neisseria meningitidis group b nhba fusion protein (rp287-953) (8008004010) mcg; recombinant neisseria meningitidis group b nada protein (rp961c) (8008004020) mcg; recombinant neisseria meningitidis group b fhbp fusion protein (rp936-741) (8008004030) mcg; outer membrane vesicles (omv) from neisseria meningitidis group b strain nz98/254 measured as amount of total protein containing the pora p1.4 (8008004040) mcg - meningococcus b, multicomponent vaccine - 適用於2個月以上兒童及成人之主動免疫接種,以預防b型奈瑟氏腦膜炎雙球菌所引起的侵入性腦膜炎雙球菌疾病。